Clinical Study
Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation
Table 3
Analysis of independent predictors of survival in the cohort of glioblastoma patients submitted to chemoradiotherapy.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CI: confidence interval; HR: hazard ratio; M: male; F: female; TMZ: temozolomide; ECOG: Eastern Cooperative Oncology Group; ns: nonsignificant. Results indicated in bold are significant. Multivariate analysis used Cox proportional hazards model with a forward stepwise regression procedure. |